Tuesday, August 6 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity
Tuesday, August 6 12:30–1:45pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Tuesday, August 6 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Tuesday, August 6 7:30–8am
Test Your Knowledge: Labs & Imaging, Pulmonology, Rheumatology and More!
Tuesday, August 6 10–11am
Alzheimer Disease in Primary Care: Early Identification and New Anti-Amyloid Treatment Options
Tuesday, August 6 10–11am
Alzheimer Disease in Primary Care: Early Identification and New Anti-Amyloid Treatment Options
Tuesday, August 6 12:30–1:45pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Tuesday, August 6 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Tuesday, August 6 12:30–1:45pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Tuesday, August 6 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Wednesday, August 7 7:45–8:45am
Curbside Consults: Top Questions from PCPs on Hypertension and Heart Failure
Wednesday, August 7 11am–12pm
Skin Deep: Mastering Benign and Malignant Conditions in Primary Care
Wednesday, August 7 10–11am
Multi-Cancer Early Detection: Overcoming Barriers to Cancer Screening
Wednesday, August 7 10–11am
Multi-Cancer Early Detection: Overcoming Barriers to Cancer Screening
Tuesday, August 6 8–9am
Two Sides of the Same Coin: A Dual-Focused Approach for Diabetes and Weight Management
Tuesday, August 6 8–9am
Two Sides of the Same Coin: A Dual-Focused Approach for Diabetes and Weight Management
Tuesday, August 6 11–11:30am
Tuesday, August 6 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Anna Beth Bradley, MD
- No relevant financial relationships disclosed.
- Michael J. Brennan, MD
- Information to come
- Amy Clouse, MD, FAAFP
- Astellas Pharma, Advisor; Astellas Pharma, Speaker
- Anelyssa D'Abreu, MD, MPH, PhD
- No relevant financial relationships disclosed.
- Oscar A. de Leon-Casasola, MD
- Kowa Pharmaceuticals, Advisor; Kowa Pharmaceuticals, Consultant
- Stephanie Faubion, MD, MBA, FACP, NCMP, IF
- No relevant financial relationships disclosed.
- Katherine E. Galluzzi, DO, CMD, FACOFP
- No relevant financial relationships disclosed.
- Rollin George, MD
- Madrigal Pharmaceuticals, Stock Holder (publicly traded company)
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- OptumRx, Consultant; Premier, Inc., Consultant
- Jonette Keri, MD, PhD
- Almirall, Advisor; L'Oreal, Advisor; Ortho Dermatologics, Advisor; Primus Pharmaceuticals, Advisor
- Mylynda B. Massart, MD, PhD
- GRAIL, LLC, Speaker
- Vani Potluri, MD
- No relevant financial relationships disclosed.
- Kartik Sehgal, MD
- Equinox Group, Inc and Scholar Rock, Inc., Consultant; Exelexis Inc., Advisor; Merck, Researcher
- Tina K. Thethi, MD, MPH
- Bayer and Eli Lilly and Company, Speaker; Bayer and Novo Nordisk, Researcher; Novo Nordisk, Consultant
- Charles Vega, MD, FAAFP
- GlaxoSmithKline and Boehringer Ingelheim, Consultant
Other Disclosures
Pamela Kushner, MD, FAAFP (Moderator, Reviewer): Speaker for Astellas, Bayer, and Corcept; Speaker & Advisor for AstraZeneca, GlaxoSmithKline, Janssen, Novo Nordisk, Lilly/BI, and Phathom; Speaker & Consultant for Haleon; Advisor for Abbott, Bausch/SALIX, Intuity, and Pfizer; Consultant for Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, and Lilly.
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.